Gestational age-dependent changes in gene expression of metabolic enzymes and transporters in pregnant mices

Drug Metabolism and Disposition

Volumn 41, Issue 2, 2013, Pages 332-342

  Shuster, Diana L ^a   Bammler, Theo K ^a   Beyer, Richard P ^a   MacDonald, James W ^a   Tsai, Jesse M ^a   Farin, Frederico M ^a   Hebert, Mary F ^a,b   Thummel, Kenneth E ^a   Mao, Qingcheng ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2; CYTOCHROME P450 3A11; GLUCURONOSYLTRANSFERASE; ORGANIC CATION TRANSPORTER 3; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

ABC GENE; ABCB1A GENE; ABCC3 GENE; ABCC4 GENE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE ACID METABOLISM; CONTROLLED STUDY; CYP GENE; CYP17A1 GENE; CYP1A2 GENE; CYP2 GENE; CYP2D40 GENE; CYP3A11 GENE; CYP3A13 GENE; CYP3A16 GENE; CYP3A41A GENE; CYP3A41B GENE; CYP3A44 GENE; DRUG DISPOSITION; DRUG TRANSPORT; FEMALE; FETUS; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GESTATIONAL AGE; KIDNEY; LIVER; MALE; MOTHER; MOUSE; NONHUMAN; OCT3 GENE; PLACENTA; PREGNANCY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SLC GENE; SLC22A3 GENE; SLCO GENE; SLCO4C1 GENE; SMALL INTESTINE; STEROID METABOLISM; SULT GENE; UGT GENE; XENOBIOTIC METABOLISM;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GESTATIONAL AGE; GLUCURONOSYLTRANSFERASE; INTESTINE, SMALL; ISOENZYMES; KIDNEY; LIVER; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGANIC ANION TRANSPORTERS; PLACENTA; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SUBSTRATE SPECIFICITY; SULFOTRANSFERASES;

MUS;

EID: 84872705756     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.112.049718     Document Type: Article

References (45)

1. Aleksunes LM, Cui Y, and Klaassen CD (2008) Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta. Drug Metab Dispos 36:1960-1970.
2. Aleksunes LM, Yeager RL, Wen X, Cui JY, and Klaassen CD (2012) Repression of hepatobiliary transporters and differential regulation of classic and alternative bile Acid pathways in mice during pregnancy. Toxicol Sci 130:257-268.
3. Anderson GD (2005) Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 44:989-1008. (Pubitemid 41356388)
4. Anderson GD, Farin FM, Bammler TK, Beyer RP, Swan AA, Wilkerson HW, Kantor ED, and Hoane MR (2011) The effect of progesterone dose on gene expression after traumatic brain injury. J Neurotrauma 28:1827-1843.
5. Anger GJ and Piquette-Miller M (2008) Pharmacokinetic studies in pregnant women. Clin Pharmacol Ther 83:184-187.
6. Barkley MS, Geschwind II, and Bradford GE (1979) The gestational pattern of estradiol, testosterone and progesterone secretion in selected strains of mice. Biol Reprod 20: 733-738. (Pubitemid 9184941)
7. Carlin A and Alfirevic Z (2008) Physiological changes of pregnancy and monitoring. Best Pract Res Clin Obstet Gynaecol 22:801-823.
8. Carvalho BS and Irizarry RA (2010) A framework for oligonucleotide microarray preprocessing. Bioinformatics 26:2363-2367.
9. Clore J, Schoolwerth A, and Watlington CO (1992) When is cortisol a mineralocorticoid? Kidney Int 42:1297-1308.
10. Cole TB, Beyer RP, Bammler TK, Park SS, Farin FM, Costa LG, and Furlong CE (2011) Repeated developmental exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1)-modulated effects on cerebellar gene expression. Toxicol Sci 123:155-169.
11. Dabney AR and Storey JD (2006) A reanalysis of a published Affymetrix GeneChip control dataset. Genome Biol 7:401.
12. Davison JM and Hytten FE (1975) The effect of pregnancy on the renal handling of glucose. Br J Obstet Gynaecol 82:374-381.
13. Dempsey D, Jacob P, 3rd, and Benowitz NL (2002) Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 301:594-598. (Pubitemid 34429972)
14. Dörr HG, Heller A, Versmold HT, Sippell WG, Herrmann M, Bidlingmaier F, and Knorr D (1989) Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy. J Clin Endocrinol Metab 68:863-868. (Pubitemid 19127401)
15. Evans SJ, Datson NA, Kabbaj M, Thompson RC, Vreugdenhil E, De Kloet ER, Watson SJ, and Akil H (2002) Evaluation of Affymetrix Gene Chip sensitivity in rat hippocampal tissue using SAGE analysis. Serial Analysis of Gene Expression. Eur J Neurosci 16:409-413. (Pubitemid 35471858)
16. Feghali MN and Mattison DR (2011) Clinical therapeutics in pregnancy. J Biomed Biotechnol 2011:783528.
17. Gutierrez PS, Monteoliva D, and Diambra L (2012) Cooperative binding of transcription factors promotes bimodal gene expression response. PLoS ONE 7:e44812.
18. Hakkola J, Raunio H, Purkunen R, Pelkonen O, Saarikoski S, Cresteil T, and Pasanen M (1996) Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem Pharmacol 52:379-383. (Pubitemid 26233768)
19. Hebert MF, Easterling TR, Kirby B, Carr DB, Buchanan ML, Rutherford T, Thummel KE, Fishbein DP, and Unadkat JD (2008) Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther 84:248-253.
20. Hebert MF, Ma X, and Naraharisetti SB, Krudys KM, Umans JG, Hankins GD, Caritis SN, Miodovnik M, Mattison DR, Unadkat JD, et al.Obstetric-Fetal Pharmacology Research Unit Network (2009) Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 85:607-614.
21. Hodge LS and Tracy TS (2007) Alterations in drug disposition during pregnancy: implications for drug therapy. Expert Opin Drug Metab Toxicol 3:557-571. (Pubitemid 351324964)
22. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, and Speed TP (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
23. Jarukamjorn K, Sakuma T, Jaruchotikamol A, Ishino Y, Oguro M, and Nemoto N (2006) Modified expression of cytochrome P450 mRNAs by growth hormone in mouse liver. Toxicology 219:97-105. (Pubitemid 43120710)
24. Jonker JW, Smit JW, Brinkhuis RF, Maliepaard M, Beijnen JH, Schellens JH, and Schinkel AH (2000) Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 92:1651-1656.
25. Klieger C, Pollex E, Kazmin A, and Koren G (2009) Hypoglycemics: pharmacokinetic considerations during pregnancy. Ther Drug Monit 31:533-541.
26. Koh KH, Xie H, Yu AM, and Jeong H (2011) Altered cytochrome P450 expression in mice during pregnancy. Drug Metab Dispos 39:165-169.
27. Malassiné A, Frendo JL, and Evain-Brion D (2003) A comparison of placental development and endocrine functions between the human and mouse model. Hum Reprod Update 9:531-539. (Pubitemid 38072146)
28. Martignoni M, Groothuis GM, and de Kanter R (2006) Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2:875-894. (Pubitemid 44911538)
29. Mathias AA, Maggio-Price L, Lai Y, Gupta A, and Unadkat JD (2006) Changes in pharmacokinetics of anti-HIV protease inhibitors during pregnancy: the role of CYP3A and P-glycoprotein. J Pharmacol Exp Ther 316:1202-1209. (Pubitemid 43345295)
30. Milona A, Owen BM, and Cobbold JF, Willemsen EC, Cox IJ, Boudjelal M, Cairns W, Schoonjans K, Taylor-Robinson SD, Klomp LW, et al. (2010) Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function. Hepatology 52:1341-1349.
31. Raunig JM, Yamauchi Y, Ward MA, and Collier AC (2011) Assisted reproduction technologies alter steroid delivery to the mouse fetus during pregnancy. J Steroid Biochem Mol Biol 126: 26-34.
32. Sakuma T, Endo Y, Mashino M, Kuroiwa M, Ohara A, Jarukamjorn K, and Nemoto N (2002) Regulation of the expression of two female-predominant CYP3A mRNAs (CYP3A41 and CYP3A44) in mouse liver by sex and growth hormones. Arch Biochem Biophys 404: 234-242. (Pubitemid 34913554)
33. Sakuma T, Kitajima K, Nishiyama M, Endo Y, Miyauchi K, Jarukamjorn K, and Nemoto N (2004) Collaborated regulation of female-specific murine Cyp3a41 gene expression by growth and glucocorticoid hormones. Biochem Biophys Res Commun 314:495-500. (Pubitemid 38084745)
34. Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, and Selbach M (2011) Global quantification of mammalian gene expression control. Nature 473:337-342.
35. Smit JW, Huisman MT, van Tellingen O, Wiltshire HR, and Schinkel AH (1999) Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest 104:1441-1447.
36. Smyth GK (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3.
37. Stamper BD, Park SS, Beyer RP, Bammler TK, Farin FM, Mecham B, and Cunningham ML (2011) Differential expression of extracellular matrix-mediated pathways in single-suture craniosynostosis. PLoS ONE 6:e26557.
38. Tracy TS, Venkataramanan R, Glover DD, and Caritis SN; National Institute for Child Health and Human Development Network of Maternal-Fetal-Medicine Units (2005) Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy. Am J Obstet Gynecol 192:633-639. (Pubitemid 40215007)
39. Tusher VG, Tibshirani R, and Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121. (Pubitemid 32397092)
40. Unadkat JD, Wara DW, and Hughes MD, Mathias AA, Holland DT, Paul ME, Connor J, Huang S, Nguyen BY, Watts DH, Mofenson LM, et al. (2007) Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother 51:783-786. (Pubitemid 46185308)
41. Wang H, Wu X, Hudkins K, Mikheev A, Zhang H, Gupta A, Unadkat JD, and Mao Q (2006) Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors. Am J Physiol Endocrinol Metab 291:E1295-E1304. (Pubitemid 44904038)
42. Zhang H, Wu X, Wang H, Mikheev AM, Mao Q, and Unadkat JD (2008) Effect of pregnancy on cytochrome P450 3a and P-glycoprotein expression and activity in the mouse: mechanisms, tissue specificity, and time course. Mol Pharmacol 74:714-723.
43. Zhang Y, Wang H, Unadkat JD, and Mao Q (2007) Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse. Drug Metab Dispos 35:2154-2158. (Pubitemid 350146200)
44. Zhou L, Naraharisetti SB, Wang H, Unadkat JD, Hebert MF, and Mao Q (2008) The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Mol Pharmacol 73:949-959. (Pubitemid 351397899)
45. Zhou L, Zhang Y, Hebert MF, Unadkat JD, and Mao Q (2010) Increased glyburide clearance in the pregnant mouse model. Drug Metab Dispos 38:1403-1406.